Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

NCT06556004 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage IIIc
Melanoma Stage IV

Interventions

BIOLOGICAL: TRIMELVAX

Sponsor

University of Chile

Collaborators

[object Object]